Cite Filings / CCCC / 0000902664-26-001046

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

C4 Therapeutics, Inc. Filed 2026-02-17 Acc 0000902664-26-001046

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-18 4 Chief Business Officer gave up 9,004 shares (to pay taxes)
2026-02-18 4 Chief Scientific Officer gave up 2,446 shares (to pay taxes)
2026-02-18 4 Chief People Officer gave up 9,004 shares (to pay taxes)
2026-02-18 4 Chief Financial Officer gave up 17,244 shares (to pay taxes)
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…